Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Stepanova

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
Annals of Hepatology|September 14, 2024
Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA regionSaleh A Alqahtani, Yusuf Yilmaz, Mohamed El-Kassas, et al.
Gastroenterology|December 11, 2020
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 17, 2016
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated CirrhosisZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Hepatology (Baltimore, Md.)|January 14, 2009
Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirinZobair M Younossi, Ancha Baranova, Arian Afendy, et al.
Journal of Clinical and Experimental Hepatology|April 21, 2025
Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver DiseaseZobair M Younossi, Michael J Estep, Sean Felix, et al.
Journal of Hepatology|September 6, 2015
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirinZobair M Younossi, Maria Stepanova, Michael Estep, et al.
Annals of Hepatology|November 1, 2020
Health-related quality of life in Cuban patients with chronic liver disease: A real-world experienceMarlen I Castellanos-Fernández, Susana A Borges-González, Maria Stepanova, et al.
Journal of Viral Hepatitis|July 6, 2018
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infectionZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Hepatology Communications|November 9, 2020
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported OutcomesZobair M Younossi, Vincent Wai-Sun Wong, Quentin M Anstee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2021
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim AnalysisZobair M Younossi, Maria Stepanova, Fatema Nader, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Annals of Hepatology|September 14, 2024
Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA regionSaleh A Alqahtani, Yusuf Yilmaz, Mohamed El-Kassas, et al.
Gastroenterology|December 11, 2020
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 17, 2016
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated CirrhosisZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Hepatology (Baltimore, Md.)|January 14, 2009
Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirinZobair M Younossi, Ancha Baranova, Arian Afendy, et al.
Journal of Clinical and Experimental Hepatology|April 21, 2025
Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver DiseaseZobair M Younossi, Michael J Estep, Sean Felix, et al.
Journal of Hepatology|September 6, 2015
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirinZobair M Younossi, Maria Stepanova, Michael Estep, et al.
Annals of Hepatology|November 1, 2020
Health-related quality of life in Cuban patients with chronic liver disease: A real-world experienceMarlen I Castellanos-Fernández, Susana A Borges-González, Maria Stepanova, et al.
Journal of Viral Hepatitis|July 6, 2018
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infectionZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Hepatology Communications|November 9, 2020
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported OutcomesZobair M Younossi, Vincent Wai-Sun Wong, Quentin M Anstee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2021
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim AnalysisZobair M Younossi, Maria Stepanova, Fatema Nader, et al.
Pageof 25